References
- Pascucci A. Granulomatous drug eruption associated with imipramine. JAAD Case Rep. 2018;4(2):152–154. doi:10.1016/j.jdcr.2017.11.004
- Brown-Joel ZO, Stone MS. Reactive granulomatous dermatitis in association with topiramate ingestion. Clin Exp Dermatol. 2019;44(7):833–834. doi:10.1111/ced.13923
- Grose E, Ramien M. Interstitial granulomatous drug reaction related to hydrochlorothiazide. Dermatol Online J. 2019;25(7):13030/qt1gs433hj.
- Lee HW, Yun WJ, Lee MW, et al. Interstitial granulomatous drug reaction caused by Chinese herbal medication. J Am Acad Dermatol. 2005;52(4):712–713. doi:10.1016/j.jaad.2004.11.028
- Trinidad C, Nelson KC, Glitza Oliva IC, et al. Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern. J Cutan Pathol. 2018;45(7):504–507. doi:10.1111/cup.13150
- Aria AB, Chen L, Huen AO. A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report. SAGE Open Med Case Rep. 2018;6:2050313X18795075. doi:10.1177/2050313X18795075